CytoTronics is an innovative company revolutionizing the drug discovery process through cutting-edge technology developed from a decade of research at Harvard. The company has created a proprietary semiconductor-cell interface that allows for high-dimensional functional assessments of live-cell responses at scale. Their flagship Pixel™ family of cloud-enabled cell-plate readers provides high-resolution, multiplexed, real-time analysis of live cell characteristics, yielding profound insights into the impacts of chemical or genetic perturbations on cell function. With a robust emphasis on software development, CytoTronics caters to a wide array of applications ranging from embedded systems to cloud-based data analysis, playing a pivotal role in accelerating the discovery of new drugs and therapeutics.